TCI Wealth Advisors’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
Other funds holding OMIC
DM
AVM
PA
CC
TCI Wealth Advisors's OMIC Position: Q1 2023 in Review
TCI Wealth Advisors sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2023, closing a stake of 16 shares — an estimated $949 sold.
TCI Wealth Advisors first reported a position in OMIC in Q1 2022 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 66 funds tracked by Wall St. Rank hold OMIC as of Q1 2023.
- TCI Wealth Advisors reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 16 Singular Genomics Systems, Inc. Common Stock shares in Q1 2023, an estimated $949.
- TCI Wealth Advisors first reported a position in Singular Genomics Systems, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
- TCI Wealth Advisors's Singular Genomics Systems, Inc. Common Stock position peaked at $1K in Q2 2022.
- 66 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2023.
Based on TCI Wealth Advisors's 13F filing for Q1 2023, filed 3 May 2023.